http://www.physorg.com/ en-us Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine. New research findings out of Wake Forest University School of Medicine and the University of Wisconsin may help provide some direction for men diagnosed with prostate cancer about whether their cancer is likely to be life-threatening. http://www.physorg.com/news153738140.html Medicine & Health Fri, 13 Feb 2009 09:03:24 EST news153738140 Researchers from the University of Michigan Comprehensive Cancer Center have identified a panel of small molecules, or metabolites, that appear to indicate aggressive prostate cancer. http://www.physorg.com/news153580723.html Medicine & Health Wed, 11 Feb 2009 13:19:24 EST news153580723 Scientists at Melbourne's Burnet Institute have developed a potential new treatment for patients with prostate cancer. An article, which described the invention, has recently been published in the prestigious international journal The Journal of Clinical Investigation. http://www.physorg.com/news153137645.html Medicine & Health Fri, 06 Feb 2009 10:14:49 EST news153137645 (PhysOrg.com) -- Blocking a specific protein complex prevents the formation of tumors in mice genetically predisposed to develop prostate cancer, researchers at the Whitehead Institute for Biomedical Research have found. Interestingly, inhibiting this protein complex in non-cancer cells appears to have no impact, suggesting that the protein complex may represent a promising target for drug development. http://www.physorg.com/news152896902.html Medicine & Health Tue, 03 Feb 2009 15:22:09 EST news152896902 A new study at the University of Haifa discovered: Worldwide, countries with the highest levels of artificial light at night also have the highest rates of prostate cancer. http://www.physorg.com/news152885287.html Medicine & Health Tue, 03 Feb 2009 12:08:54 EST news152885287 Men who develop prostate cancer face an increased risk of having an aggressive tumor if they carry a so-called breast cancer gene mutation, scientists from the Albert Einstein College of Medicine of Yeshiva University report in today's issue of Clinical Cancer Research. The findings could help to guide prostate-cancer patients and their physicians in choosing treatment options. http://www.physorg.com/news152470146.html Medicine & Health Thu, 29 Jan 2009 16:49:48 EST news152470146 Men who are very sexually active in their twenties and thirties are more likely to develop prostate cancer, especially if they masturbate frequently, according to a study of more than 800 men published in the January issue of BJU International. http://www.physorg.com/news152191908.html Medicine & Health Mon, 26 Jan 2009 11:32:12 EST news152191908 A new study appearing in The Prostate has found that certain measles virus vaccine strain derivatives, including a strain known as MV-CEA, may prove to be an effective treatment for patients with advanced prostate cancer. The findings show that this type of treatment, called virotherapy, can effectively infect, replicate in and kill prostate cancer cells. http://www.physorg.com/news151764972.html Medicine & Health Wed, 21 Jan 2009 12:56:45 EST news151764972 Government plans to make certain prescription-only drugs for common problems available over the counter have overwhelmingly been given the thumbs down by healthcare professionals, reveals a survey of readers of the influential Drug and Therapeutics Bulletin (DTB). http://www.physorg.com/news151141673.html Medicine & Health Wed, 14 Jan 2009 07:47:53 EST news151141673 Using new technologies that make it easier to sequence the human genome, researchers at the University of Michigan Comprehensive Cancer Center have identified a series of genes that become fused when their chromosomes trade places with each other. These recurrent gene fusions are thought to be the driving mechanism that causes certain cancers to develop. http://www.physorg.com/news150904093.html Medicine & Health Sun, 11 Jan 2009 13:48:13 EST news150904093 In a first of its kind study, a first-degree family history of prostate cancer has no impact on the treatment outcomes of prostate cancer patients treated with brachytherapy (also called seed implants), and patients with this type of family history have clinical and pathologic characteristics similar to men with no family history at all, according to a January 1 study in the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology. http://www.physorg.com/news150115064.html Medicine & Health Fri, 02 Jan 2009 10:37:44 EST news150115064 Gay and bisexual black men are less likely to be tested for prostate cancer than men of any other racial and ethnic backgrounds regardless of their sexual orientation, according to a recent study by a researcher at Charles Drew University of Medicine and Science. http://www.physorg.com/news149344384.html Medicine & Health Wed, 24 Dec 2008 12:33:04 EST news149344384 A study published today in the December issue of the European medical journal Anticancer Research demonstrates that an ingredient used in a common cough suppressant may be useful in treating advanced prostate cancer. Researchers found that noscapine, which has been used in cough medication for nearly 50 years, reduced tumor growth in mice by 60% and limited the spread of tumors by 65% without causing harmful side effects. http://www.physorg.com/news148885585.html Medicine & Health Fri, 19 Dec 2008 05:06:25 EST news148885585 Low-income men are more likely to present with advanced prostate cancers, most likely because they don't receive screening services shown to reduce the diagnosis of later-stage cancers, a UCLA study found. http://www.physorg.com/news148624967.html Medicine & Health Tue, 16 Dec 2008 04:42:47 EST news148624967 Just under five per cent of the men who took part in the prostate cancer element of the USA's largest ever cancer screening trial were diagnosed with the disease and the majority of those were picked up by screening programmes, according to research published in the December issue of the urology journal BJU International. http://www.physorg.com/news148561061.html Medicine & Health Mon, 15 Dec 2008 10:57:41 EST news148561061 Treating prostate cancer patients with drugs that block hormonal activity does not appear to increase the risk of death from cardiovascular disease, according to a study led by Massachusetts General Hospital (MGH) researchers. While a 2006 report from members of the same study team found that treatment with gonadotropin-releasing hormone (GnRH) agonists increased the risk of diabetes and heart disease, the current study is the first to examine whether treatment actually increased heart-disease-related deaths. In their Journal of Clinical Oncology report, which has been released online, the researchers note that GnRH agonist treatment has a number of adverse side effects, which should be kept in mind when determining treatment strategies. http://www.physorg.com/news148132191.html Medicine & Health Wed, 10 Dec 2008 11:49:51 EST news148132191 Findings from one of the largest cancer chemoprevention trials ever conducted have concluded that selenium and vitamin E taken alone or in combination for an average of five and a half years did not prevent prostate cancer, according to a team of researchers coordinated by the Southwest Oncology Group (SWOG) and led by scientists at The University of Texas M. D. Anderson Cancer Center and Cleveland Clinic. http://www.physorg.com/news148062872.html Medicine & Health Tue, 09 Dec 2008 16:34:32 EST news148062872 Although the link between early screening and prostate cancer survival is well established, men are less likely to go for early screening unless they have a wife or significant other living with them, according to a study published in Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research. http://www.physorg.com/news147927939.html Medicine & Health Mon, 08 Dec 2008 03:05:39 EST news147927939 More than 95 per cent of men who took degarelix for prostate cancer saw their testosterone levels fall dramatically as early as three days after they started treatment, according to a paper in the December issue of BJU International. http://www.physorg.com/news147529873.html Medicine & Health Wed, 03 Dec 2008 12:31:13 EST news147529873 Prostate cancer - and perhaps other cancers - promotes the growth of new nerves and the branching axons that carry their messages, a finding associated with more aggressive tumors, said researchers from Baylor College of Medicine in the first report of the phenomenon that appears today in the journal Clinical Cancer Research. http://www.physorg.com/news147358690.html Medicine & Health Mon, 01 Dec 2008 12:58:10 EST news147358690 Researchers at the University of Southern California (USC) have found that inactivating a specific biomarker for aggressive prostate cancer blocks the development of prostate cancer in animal models. http://www.physorg.com/news146767721.html Medicine & Health Mon, 24 Nov 2008 16:48:41 EST news146767721 Men with a family history of prostate cancer and African-American men are particularly susceptible to the disease, with a twofold to sevenfold increased risk. Assessing risk in these populations has been difficult. http://www.physorg.com/news146146235.html Medicine & Health Mon, 17 Nov 2008 12:10:35 EST news146146235 The use of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is significantly associated with lower PSA levels, especially among men with prostate cancer, say researchers at Vanderbilt University. http://www.physorg.com/news146062290.html Medicine & Health Sun, 16 Nov 2008 12:51:30 EST news146062290 Arnhem, 13 November 2008 -- In the December issue of European Urology (http://www.elsevier.com/locate/eururo) Dr. Curtis Nickel and associates report on the evidence of a relationship between prostate inflammation and lower urinary tract symptoms (LUTS) in men enrolled in the REDUCE trial. http://www.physorg.com/news145800523.html Medicine & Health Thu, 13 Nov 2008 12:08:43 EST news145800523 Montreal, November 13, 2008 - A new cross-Canada study has found that breast and prostate cancer treatment can foster bone loss. In the online edition of the Journal of Clinical Oncology, the scientists explain how loss of bone mass might affect 46,000 people diagnosed with breast and prostate cancer each year* and place them at increased risk for osteoporosis and fractures. http://www.physorg.com/news145799650.html Medicine & Health Thu, 13 Nov 2008 11:54:10 EST news145799650 Use of cholesterol-lowering statins is associated with a statistically significant decline in prostate specific antigen (PSA) levels, according to a report in the October 28 online issue of the Journal of the National Cancer Institute. http://www.physorg.com/news144431306.html Medicine & Health Tue, 28 Oct 2008 16:48:26 EST news144431306 (PhysOrg.com) -- Popular cholesterol-busting drugs -- statins -- appear to lower men's prostate-specific antigen (PSA) values along with their cholesterol levels, according to researchers in the Duke Prostate Center and the Durham Veterans Affairs Medical Center. But whether the drugs prevent prostate cancer growth or just mask it is not known yet. http://www.physorg.com/news144427722.html Medicine & Health Tue, 28 Oct 2008 15:48:42 EST news144427722 Prostate cancer (PCa) is one of the most common male cancers in the Western world. Currently, early detection of PCa depends on an abnormal digital rectal examination and an elevated prostate-specific-antigen (PSA) level requiring a prostate biopsy, often associated with anxiety, discomfort, complications, and heavy expenses. The prostate-cancer-gene-3 (PCA3) test is a new PCa gene-based marker carried out with a urine sample. PCA3 is highly specific to PCa and has shown promising early detection results at repeat biopsy. It may allow patients to avoid unnecessary biopsies. The PCA3 gene is dominant in over 95% of malignant prostate tissue compared to benign and normal prostate tissue. http://www.physorg.com/news143374492.html Medicine & Health Thu, 16 Oct 2008 11:14:52 EST news143374492 (PhysOrg.com) -- The greater the levels of a protein called Insulin-like Growth Factor-1 (IGF-1), the greater the risk of prostate cancer, an Oxford University-led study has found. The results are published in the journal Annals of Internal Medicine. http://www.physorg.com/news142692905.html Medicine & Health Wed, 08 Oct 2008 13:55:05 EST news142692905 Use of a class of medications for treating an enlarged prostate, known as 5-α reductase inhibitors, are not associated with an increased hip fracture risk, according to a study in the October 8 issue of JAMA. http://www.physorg.com/news142616723.html Medicine & Health Tue, 07 Oct 2008 16:45:23 EST news142616723